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ABSTRACT 
Despite the advances in understanding the pathophysiology of acute myeloid leukaemia 
(AML), the cure rate for acute myeloid leukaemia patients remains low. Cytogenetic 
abnormalities and age are the prognostic factors that guide treatment decisions. However, 
many AML patients still die. The biological factors that influence treatment outcome are 
largely unknown. Thus, the objective of our study was to use the in vitro viability test to 
correlate with treatment outcome. Acute myeloid leukaemia blasts demonstrated differing 
ability to survive in culture. Our examination of blast phenotype at various days in culture 
showed two possible growth directions. First, cells underwent maturation by increased 
expression of CD16 and down-regulated CD34 (a haemopoietic stem cell marker). These 
cells also appeared to have undergone apoptosis. Alternatively, cells continued to survive in 
culture and maintained high expression of CD34. An MTT assay was carried out to determine 
viability after three days of culture. Lower optical density values were obtained for samples 
that underwent apoptosis and higher values were obtained for samples that survived in 
culture. Apoptosis was measured by Annexin V/propidium iodide staining. A comparison 
between results of MTT assay and duration of disease free survival revealed that a higher 
viability in vitro correlated significantly with shorter survival duration in the patient (R=-
0.761, p=0.002, n=13). Thus, this study further supports the hypothesis that AML patients 
with poor survival may be related to having blasts with a biologically more immature or stem 
cell-like nature. 
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